Concomitant Administration of Direct Oral Anticoagulants in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors.

Alessandra SerraoEmilia ScalzulliLuciano FioriAlessio Di PrimaMassimo BrecciaAntonio Chistolini

Published in: Clinical drug investigation (2020)

In this small case series, the use of DOACs in CML patients seemed feasible. Additional data on long-term outcomes including a larger cohort of CML patients treated with DOACs are, however, needed.

Keyphrases

chronic myeloid leukemia
direct oral anticoagulants
venous thromboembolism
atrial fibrillation
end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
electronic health record
patient reported outcomes
machine learning